No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3ozqA1, 1.0000, 0.00, 1.000, 361, 361, CRYSTAL STRUCTURE OF SERPIN48 WHICH IS A HIGHLY SPECIFIC SERPIN IN THE INSECT TENEBRIO MOLITOR
2, d1azxI_, 0.9267, 0.00, 1.000, 361, 361, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
3, d1sekA_, 0.9258, 2.08, 0.279, 417, 359, THE STRUCTURE OF ACTIVE SERPIN K FROM MANDUCA SEXTA AND A MODEL FOR SERPIN-PROTEASE COMPLEX FORMATION
4, d3f1sA_, 0.9249, 1.89, 0.322, 376, 354, CRYSTAL STRUCTURE OF PROTEIN Z COMPLEXED WITH PROTEIN Z-DEPENDENT INHIBITOR
5, d1i99I_, 0.9243, 1.97, 0.258, 385, 353,  
6, d1k9oI_, 0.9240, 1.97, 0.258, 385, 353, CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
7, p3h5cA_, 0.9239, 1.92, 0.336, 376, 354, X-RAY STRUCTURE OF PROTEIN Z-PROTEIN Z INHIBITOR COMPLEX
8, d1e03I_, 0.9236, 1.92, 0.336, 376, 354, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
9, d1e04I_, 0.9235, 1.93, 0.336, 376, 354, PLASMA BETA ANTITHROMBIN-III
10, d2antI_, 0.9223, 1.96, 0.258, 384, 356, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
11, d2hijI1, 0.9222, 2.13, 0.279, 418, 359, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
12, d1e05I_, 0.9222, 2.19, 0.284, 403, 359, PLASMA ALPHA ANTITHROMBIN-III
13, d1nq9I_, 0.9219, 2.17, 0.284, 419, 359, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
14, d1athA_, 0.9215, 2.17, 0.279, 411, 358, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
15, d4x30A_, 0.9214, 2.18, 0.284, 417, 359, CRYSTAL STRUCTURE OF HUMAN THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROINE AT 1.55 ANGSTROM RESOLUTION
16, d2behI_, 0.9207, 1.96, 0.285, 406, 355, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
17, d2b4xI1, 0.9185, 2.13, 0.282, 389, 358, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
18, d1tb6I_, 0.9183, 2.01, 0.256, 372, 356, 2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
19, d1oyhI_, 0.9177, 2.01, 0.256, 372, 356, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
20, d1dzhI_, 0.9174, 2.02, 0.287, 413, 356, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
21, d2gd4I1, 0.9164, 2.02, 0.282, 413, 355, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
22, d2gd4C1, 0.9146, 2.01, 0.274, 412, 354, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
23, d3evjI_, 0.9145, 2.24, 0.279, 416, 359, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
24, d3kcgI_, 0.9139, 2.20, 0.285, 417, 358, CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA- PENTASACCHARIDE COMPLEX
25, d1dzgI_, 0.9126, 2.12, 0.274, 417, 354, N135Q-S380C-ANTITHROMBIN-III
26, d4dy7C_, 0.9107, 2.19, 0.274, 418, 354, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
27, d1jmjB_, 0.9106, 2.02, 0.286, 404, 353, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
28, d1antI_, 0.9103, 2.09, 0.275, 419, 353, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
29, d1ovaA_, 0.9098, 2.29, 0.284, 422, 359, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
30, p1yxaA_, 0.9097, 2.13, 0.281, 377, 352, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
31, d1jmjA_, 0.9095, 2.20, 0.259, 387, 355, CRYSTAL STRUCTURE OF NATIVE HEPARIN COFACTOR II
32, p1yxaB_, 0.9089, 2.09, 0.271, 402, 354, SERPINA3N A MURINE ORTHOLOGUE OF HUMAN ANTICHYMOTRYPSIN
33, d1ovaD_, 0.9089, 1.97, 0.274, 383, 350, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
34, d2zv6B1, 0.9085, 2.03, 0.312, 372, 349, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
35, d4dy7F_, 0.9075, 2.03, 0.312, 372, 349, CRYSTAL STRUCTURES OF PROTEASE NEXIN-1 IN COMPLEX WITH S195A THROMBIN
36, d1ovaB_, 0.9074, 2.21, 0.256, 397, 355, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
37, d2h4rA1, 0.9073, 2.15, 0.311, 368, 351, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE NATIVE CONFORMATION
38, d3pzfA_, 0.9069, 2.08, 0.276, 385, 351, 1.75A RESOLUTION STRUCTURE OF SERPIN-2 FROM ANOPHELES GAMBIAE
39, p4ga7A_, 0.9060, 2.08, 0.276, 385, 351, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
40, d1t1fC_, 0.9057, 2.00, 0.313, 370, 348, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
41, d1t1fB_, 0.9057, 2.16, 0.288, 378, 351, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
42, d1t1fA_, 0.9057, 2.16, 0.288, 378, 351, CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM
43, d1sr5A_, 0.9055, 2.12, 0.276, 371, 351, ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
44, d3r4lA_, 0.9054, 2.00, 0.331, 368, 350, HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1
45, d1ovaC_, 0.9048, 2.00, 0.331, 368, 350, CRYSTAL STRUCTURE OF UNCLEAVED OVALBUMIN AT 1.95 ANGSTROMS RESOLUTION
46, d2ceoA_, 0.9042, 2.19, 0.279, 369, 351, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
47, d2ceoB_, 0.9039, 2.19, 0.279, 369, 351, THYROXINE-BINDING GLOBULIN COMPLEX WITH THYROXINE
48, p4y40A_, 0.9033, 1.86, 0.335, 369, 346, STRUCTURE OF VASPIN MUTANT D305C V383C
49, d4roaA_, 0.9033, 2.25, 0.285, 419, 354, 1.90A RESOLUTION STRUCTURE OF SRPN2 (S358W) FROM ANOPHELES GAMBIAE
50, d4ajtA_, 0.9032, 2.25, 0.285, 419, 354, THE CRYSTAL STRUCTURE OF MOUSE PROTEIN-Z DEPENDENT PROTEASE INHIBITOR(MZPI)
51, d4dy0B_, 0.9031, 2.25, 0.285, 419, 354, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
52, d1uhgD_, 0.9030, 2.12, 0.277, 409, 350, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
53, p4if8A_, 0.9020, 2.29, 0.298, 377, 356, STRUCTURE OF VASPIN
54, d1uhgB_, 0.9019, 1.94, 0.279, 373, 348, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
55, d3le2A1, 0.9017, 2.10, 0.260, 367, 350, STRUCTURE OF ARABIDOPSIS ATSERPIN1. NATIVE STRESSED CONFORMATION
56, d1ophA_, 0.9015, 2.10, 0.260, 367, 350, NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
57, d3ne4A_, 0.9012, 1.97, 0.236, 366, 347, 1.8 ANGSTROM STRUCTURE OF INTACT NATIVE WILD-TYPE ALPHA-1-ANTITRYPSIN
58, p4ga7B_, 0.9010, 2.17, 0.275, 364, 349, CRYSTAL STRUCTURE OF HUMAN SERPINB1 MUTANT
59, d1qlpA_, 0.9009, 2.14, 0.244, 372, 349, 2.0 ANGSTROM STRUCTURE OF INTACT ALPHA-1-ANTITRYPSIN: A CANONICAL TEMPLATE FOR ACTIVE SERPINS
60, p3f5nA_, 0.9006, 2.13, 0.284, 370, 349, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
61, p4y3kA_, 0.8996, 2.00, 0.279, 380, 348, STRUCTURE OF VASPIN MUTANT E379S
62, p5nbuA_, 0.8995, 2.00, 0.236, 367, 347, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
63, d5hgcA1, 0.8995, 2.10, 0.275, 380, 349, A SERPIN STRUCTURE
64, d1db2A_, 0.8995, 2.34, 0.261, 391, 353, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
65, d1hp7A_, 0.8993, 2.34, 0.261, 391, 353, A 2.1 ANGSTROM STRUCTURE OF AN UNCLEAVED ALPHA-1-ANTITRYPSIN SHOWS VARIABILITY OF THE REACTIVE CENTER AND OTHER LOOPS
66, d1uhgC_, 0.8992, 2.24, 0.291, 375, 351, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
67, d1oo8A_, 0.8989, 2.18, 0.282, 370, 351, CRYSTAL STRUCTURE OF A1PI-PITTSBURGH IN THE NATIVE CONFORMATION
68, d5ncsA1, 0.8982, 1.84, 0.334, 367, 344, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
69, d1r1lI_, 0.8980, 2.28, 0.276, 372, 352, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
70, d2zv6A_, 0.8976, 2.02, 0.347, 364, 346, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
71, p2dutD_, 0.8975, 2.04, 0.236, 367, 347, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
72, p2dutC_, 0.8975, 2.31, 0.287, 370, 352, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
73, p2dutB_, 0.8975, 2.29, 0.272, 368, 349, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
74, p2dutA_, 0.8975, 2.29, 0.272, 368, 349, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE NATIVE CONFORMATION
75, d1uhgA_, 0.8975, 2.45, 0.294, 377, 357, CRYSTAL STRUCTURE OF S-OVALBUMIN AT 1.9 ANGSTROM RESOLUTION
76, d5ncsB1, 0.8972, 2.42, 0.288, 376, 354, STRUCTURE OF THE NATIVE SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
77, d2qugA_, 0.8971, 2.42, 0.288, 376, 354, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM A
78, d1lk6I_, 0.8969, 2.01, 0.282, 370, 347, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
79, p3f5nD_, 0.8965, 2.28, 0.285, 370, 351, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
80, d1psiA_, 0.8965, 2.06, 0.264, 370, 345, INTACT RECOMBINED ALPHA1-ANTITRYPSIN MUTANT PHE 51 TO LEU
81, d3cwlA_, 0.8963, 2.06, 0.264, 370, 345, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN CRYSTAL FORM B
82, d3cwmA_, 0.8961, 2.54, 0.281, 416, 359, CRYSTAL STRUCTURE OF ALPHA-1-ANTITRYPSIN COMPLEXED WITH CITRATE
83, d1jvqI_, 0.8959, 1.58, 0.316, 350, 339, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
84, d2zv6C1, 0.8953, 2.00, 0.334, 366, 347, CRYSTAL STRUCTURE OF HUMAN SQUAMOUS CELL CARCINOMA ANTIGEN 1
85, d1br8I_, 0.8934, 2.00, 0.334, 366, 347, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
86, p3druA_, 0.8933, 2.00, 0.334, 366, 347, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
87, d4rsqK_, 0.8932, 2.00, 0.334, 366, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
88, d4p0oA_, 0.8931, 2.00, 0.286, 378, 346, CLEAVED SERPIN 42DA
89, d2peeB_, 0.8931, 2.08, 0.267, 370, 345, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
90, p3fgqB_, 0.8930, 2.25, 0.280, 368, 350, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
91, p3fgqA_, 0.8929, 2.37, 0.272, 410, 356, CRYSTAL STRUCTURE OF NATIVE HUMAN NEUROSERPIN
92, d4dy0A_, 0.8928, 1.91, 0.344, 363, 343, CRYSTAL STRUCTURE OF NATIVE PROTEASE NEXIN-1 WITH HEPARIN
93, p5cdxA_, 0.8923, 2.20, 0.286, 371, 350, CRYSTAL STRUCTURE OF CONSERPIN
94, d2peeA_, 0.8923, 2.30, 0.277, 371, 350, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE NATIVE STATE
95, p3vvjC_, 0.8919, 2.18, 0.275, 369, 349, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
96, d4robB_, 0.8918, 2.38, 0.272, 410, 356, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
97, p5ce0B_, 0.8916, 1.56, 0.317, 349, 338, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
98, p3druB_, 0.8909, 2.35, 0.274, 404, 354, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
99, d4rsqE_, 0.8906, 2.13, 0.282, 363, 347, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
100, p5io1A_, 0.8905, 2.14, 0.270, 356, 344, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
101, p3druC_, 0.8903, 2.26, 0.353, 371, 351, CRYSTAL STRUCTURE OF GLY117PHE ALPHA1-ANTITRYPSIN
102, d1jmoA_, 0.8902, 2.26, 0.353, 371, 351, CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
103, p5io1B_, 0.8900, 2.30, 0.271, 387, 350, CRYSTAL STRUCTURE OF RECOMBINANT HUMAN Z ALPHA-1-ANTITRYPSIN
104, d4rsqH_, 0.8894, 2.16, 0.339, 374, 348, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
105, p4if8B_, 0.8894, 2.16, 0.339, 374, 348, STRUCTURE OF VASPIN
106, p5nbvA_, 0.8889, 2.16, 0.339, 374, 348, CRYSTAL STRUCTURE OF NATIVE ALPHA-1-ANTITRYPSIN WITH SEVEN STABILISING MUTATIONS
107, d4rsqG_, 0.8889, 2.02, 0.288, 362, 344, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
108, p3vvjA_, 0.8889, 1.91, 0.377, 353, 342, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
109, p3vvjB_, 0.8886, 2.31, 0.271, 387, 350, STRUCTURE OF OVALBUMIN FROM EMU (DROMAIUS NOVAEHOLLANDIAE)
110, p3f5nB_, 0.8885, 2.31, 0.271, 387, 350, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
111, d4rsqA_, 0.8884, 2.18, 0.301, 384, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
112, d2b5tI_, 0.8883, 2.14, 0.267, 356, 344, 2.1 ANGSTROM STRUCTURE OF A NONPRODUCTIVE COMPLEX BETWEEN ANTITHROMBIN SYNTHETIC HEPARIN MIMETIC SR123781 AND TWO S195A THROMBIN MOLECULES
113, d4rsqL_, 0.8882, 1.81, 0.374, 353, 340, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
114, d1attB_, 0.8882, 2.18, 0.285, 362, 347, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
115, p4y40B_, 0.8873, 2.29, 0.270, 356, 345, STRUCTURE OF VASPIN MUTANT D305C V383C
116, d3drmA_, 0.8872, 2.31, 0.276, 365, 348, 2.2 ANGSTROM CRYSTAL STRUCTURE OF THR114PHE ALPHA1- ANTITRYPSIN
117, d5du3B_, 0.8868, 2.23, 0.282, 360, 347, ACTIVE FORM OF HUMAN C1-INHIBITOR
118, d1by7A_, 0.8865, 2.29, 0.261, 425, 349, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2. LOOP (66-98) DELETION MUTANT
119, d4rsqB_, 0.8864, 2.29, 0.261, 425, 349, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
120, p5ce0A_, 0.8861, 2.34, 0.276, 364, 348, CRYSTAL STRUCTURE OF CONSERPIN WITH Z-MUTATION
121, d4robA_, 0.8861, 2.17, 0.271, 357, 343, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
122, d5du3A_, 0.8860, 1.96, 0.237, 361, 342, ACTIVE FORM OF HUMAN C1-INHIBITOR
123, d4rsqF_, 0.8858, 2.46, 0.286, 369, 350, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
124, p6cj7A_, 0.8854, 2.21, 0.267, 357, 344, CRYSTAL STRUCTURE OF MANDUCA SEXTA SERINE PROTEASE INHIBITOR (SERPIN)- 12 
125, d5duqA_, 0.8853, 2.22, 0.304, 384, 349, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
126, d1attA_, 0.8852, 2.22, 0.301, 384, 349, CRYSTAL STRUCTURE OF CLEAVED BOVINE ANTITHROMBIN III AT 3.2 ANGSTROMS RESOLUTION
127, p4y3kB_, 0.8851, 1.89, 0.353, 366, 340, STRUCTURE OF VASPIN MUTANT E379S
128, d1imvA_, 0.8850, 2.12, 0.272, 356, 342, 2.85 A CRYSTAL STRUCTURE OF PEDF
129, p2hi9A_, 0.8848, 2.50, 0.285, 415, 354, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
130, d4dteB_, 0.8840, 2.18, 0.265, 356, 343, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
131, d4rsqI_, 0.8837, 2.32, 0.276, 410, 351, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
132, p2r9yA_, 0.8833, 1.95, 0.235, 361, 341, STRUCTURE OF ANTIPLASMIN
133, d5duqB_, 0.8832, 2.11, 0.276, 362, 344, ACTIVE HUMAN C1-INHIBITOR IN COMPLEX WITH DEXTRAN SULFATE
134, d4rsqJ_, 0.8832, 2.08, 0.250, 377, 344, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
135, d1jtiB_, 0.8831, 1.78, 0.325, 354, 338, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
136, d1jtiA_, 0.8830, 2.19, 0.266, 355, 342, LOOP-INSERTED STRUCTURE OF P1-P1  CLEAVED OVALBUMIN MUTANT R339T
137, d1oc0A_, 0.8829, 1.82, 0.373, 352, 338, PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX WITH SOMATOMEDIN B DOMAIN OF VITRONECTIN
138, d4rsqD_, 0.8828, 2.21, 0.268, 356, 343, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
139, p2hi9B_, 0.8826, 2.08, 0.250, 378, 344, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
140, d1xqgB1, 0.8824, 2.08, 0.250, 378, 344, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
141, d4dteA_, 0.8823, 2.10, 0.270, 353, 341, CRYSTAL STRUCTURE OF ZEBRAFISH PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI- 1)
142, d1xu8B1, 0.8819, 2.10, 0.283, 357, 343, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
143, p2ol2A_, 0.8817, 2.06, 0.248, 362, 343, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
144, d1db2B_, 0.8816, 2.34, 0.280, 420, 350, CRYSTAL STRUCTURE OF NATIVE PLASMINOGEN ACTIVATOR INHIBITOR- 2 1
145, d4ro9A_, 0.8815, 1.99, 0.238, 361, 341, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
146, d1xqgA1, 0.8815, 2.25, 0.211, 375, 346, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP P 4 21 2
147, d5brrI_, 0.8814, 2.25, 0.211, 375, 346, MICHAELIS COMPLEX OF TPA-S195A:PAI-1
148, d1dvmD_, 0.8811, 2.05, 0.250, 356, 340, ACTIVE FORM OF HUMAN PAI-1
149, d1dvmA_, 0.8807, 2.36, 0.261, 364, 349, ACTIVE FORM OF HUMAN PAI-1
150, d1xu8A1, 0.8806, 2.21, 0.269, 356, 342, THE 2.8 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
151, d3pb1I_, 0.8805, 2.10, 0.245, 365, 343, CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
152, d4eb1I_, 0.8799, 2.10, 0.245, 365, 343, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
153, d4rsqC_, 0.8796, 2.09, 0.251, 365, 343, 2.9A RESOLUTION STRUCTURE OF SRPN2 (K198C/E359C) FROM ANOPHELES GAMBIAE
154, d1xqjA1, 0.8788, 2.22, 0.269, 355, 342, 3.10 A CRYSTAL STRUCTURE OF MASPIN SPACE GROUP I 4 2 2
155, p3f5nC_, 0.8787, 2.20, 0.280, 381, 346, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
156, d4robC_, 0.8782, 2.20, 0.280, 381, 346, 2.8A RESOLUTION STRUCTURE OF SRPN2 (K198C) FROM ANOPHELES GAMBIAE
157, d1b3kA_, 0.8780, 2.39, 0.294, 364, 350, PLASMINOGEN ACTIVATOR INHIBITOR-1
158, d1b3kC_, 0.8779, 2.25, 0.269, 355, 342, PLASMINOGEN ACTIVATOR INHIBITOR-1
159, d1as4.1, 0.8773, 2.03, 0.250, 354, 340, CLEAVED ANTICHYMOTRYPSIN A349R
160, d3ndaA_, 0.8772, 2.47, 0.269, 375, 350, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
161, d2ach.1, 0.8771, 2.38, 0.251, 374, 350, CRYSTAL STRUCTURE OF CLEAVED HUMAN ALPHA1-ANTICHYMOTRYPSIN AT 2.7 ANGSTROMS RESOLUTION AND ITS COMPARISON WITH OTHER SERPINS
162, d1dvmB_, 0.8770, 2.38, 0.251, 374, 350, ACTIVE FORM OF HUMAN PAI-1
163, d4zk0A_, 0.8763, 2.58, 0.269, 372, 350, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. HIGH PH STRUCTURE
164, d4zk3A_, 0.8762, 1.99, 0.254, 360, 339, PSORIASIS PATHOGENESIS - PSO P27 CONSTITUTE A COMPACT STRUCTURE FORMING LARGE AGGREGATES. LOW PH STRUCTURE
165, d3q02A_, 0.8760, 1.99, 0.254, 360, 339, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
166, d3q03A_, 0.8756, 2.33, 0.294, 362, 347, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
167, d3ut3C_, 0.8751, 2.13, 0.268, 353, 340, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
168, p2hi9C_, 0.8751, 2.48, 0.269, 375, 350, CRYSTAL STRUCTURE OF HUMAN NATIVE PROTEIN C INHIBITOR
169, d4g8oC1, 0.8743, 2.48, 0.269, 375, 350, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
170, d4g8oD1, 0.8741, 2.36, 0.301, 372, 349, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
171, d1kctA_, 0.8739, 2.57, 0.297, 372, 350, ALPHA1-ANTITRYPSIN
172, d3q03B_, 0.8737, 2.62, 0.299, 375, 351, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
173, d3q02B_, 0.8731, 2.35, 0.268, 364, 347, CRYSTAL STRUCTURE OF PLASMINOGEN ACTIVATOR INHIBITOR-1 IN A METASTABLE ACTIVE CONFORMATION.
174, d4ic0A_, 0.8727, 2.68, 0.296, 375, 351, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
175, d3ut3A_, 0.8727, 2.86, 0.276, 411, 355, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
176, d3ut3D_, 0.8726, 2.18, 0.271, 354, 340, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
177, d4p0fA_, 0.8725, 2.52, 0.269, 375, 350, CLEAVED SERPIN 42DA (C 2 2 21)
178, d4ic0C_, 0.8724, 1.92, 0.339, 358, 336, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
179, d4g8rB1, 0.8724, 2.18, 0.268, 351, 339, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
180, d1hle.1, 0.8724, 2.68, 0.302, 373, 351, CRYSTAL STRUCTURE OF CLEAVED EQUINE LEUCOCYTE ELASTASE INHIBITOR DETERMINED AT 1.95 ANGSTROMS RESOLUTION
181, d3ut3B_, 0.8723, 2.74, 0.301, 373, 352, A NOVEL PAI-I INHIBITOR AND ITS STRUCTURAL MECHANISM
182, d4ro9B_, 0.8722, 2.24, 0.316, 369, 345, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
183, d1dvmC_, 0.8721, 2.41, 0.319, 374, 348, ACTIVE FORM OF HUMAN PAI-1
184, p3zhaD_, 0.8720, 2.41, 0.319, 374, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
185, p3b9fI_, 0.8710, 2.30, 0.311, 372, 347, 1.6 A STRUCTURE OF THE PCI-THROMBIN-HEPARIN COMPLEX
186, d4ic0D_, 0.8707, 2.57, 0.303, 365, 350, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
187, d4c41A_, 0.8695, 2.25, 0.316, 367, 345, CORTICOSTEROID-BINDING GLOBULIN WITH ENGINEERED DISULPHIDE BRIDGE BETWEEN RESIDUES 100 AND 236
188, d3caa.1, 0.8693, 2.41, 0.312, 366, 346, CLEAVED ANTICHYMOTRYPSIN A347R
189, p2ol2B_, 0.8692, 2.26, 0.299, 358, 344, HIGH RESOLUTION STRUCTURE OF NATIVE PCI IN SPACE GROUP P21
190, d4ic0B_, 0.8689, 2.27, 0.299, 360, 344, CRYSTAL STRUCTURE OF PAI-1 IN COMPLEX WITH GALLATE
191, d2vdxA_, 0.8689, 2.52, 0.297, 368, 347, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
192, d4c49A_, 0.8683, 1.93, 0.251, 346, 335, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
193, d2vdyB_, 0.8672, 2.51, 0.298, 366, 346, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
194, d4c49B_, 0.8671, 2.51, 0.298, 366, 346, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
195, d1wz9B_, 0.8668, 2.56, 0.283, 375, 350, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
196, d1b3kB_, 0.8666, 2.47, 0.297, 364, 347, PLASMINOGEN ACTIVATOR INHIBITOR-1
197, d1b3kD_, 0.8664, 2.40, 0.296, 362, 345, PLASMINOGEN ACTIVATOR INHIBITOR-1
198, d4g8rA_, 0.8661, 2.53, 0.298, 366, 346, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
199, d4g8oB1, 0.8655, 2.52, 0.298, 367, 346, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
200, d4g8oA1, 0.8650, 2.45, 0.298, 360, 346, CRYSTAL STRUCTURE OF A NOVEL SMALL MOLECULE INACTIVATOR BOUND TO PLASMINOGEN ACTIVATOR INHIBITOR-1
201, p3zhaB_, 0.8650, 2.25, 0.362, 369, 343, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
202, d4c49C_, 0.8645, 2.53, 0.298, 366, 346, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
203, d4caa.1, 0.8641, 2.57, 0.301, 367, 346, CLEAVED ANTICHYMOTRYPSIN T345R
204, p3f5nE_, 0.8638, 2.44, 0.337, 375, 347, STRUCTURE OF NATIVE HUMAN NEUROSERPIN
205, d1atuA_, 0.8638, 2.44, 0.337, 375, 347, UNCLEAVED ALPHA-1-ANTITRYPSIN
206, d2vdxB_, 0.8632, 2.44, 0.301, 360, 346, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN
207, d1a7cA_, 0.8630, 2.13, 0.271, 348, 336, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE
208, d3ndaB_, 0.8627, 2.43, 0.301, 364, 346, CRYSTAL STRUCTURE OF SERPIN FROM TICK IXODES RICINUS
209, d2antL_, 0.8623, 2.58, 0.256, 368, 351, THE 2.6 A STRUCTURE OF ANTITHROMBIN INDICATES A CONFORMATIONAL CHANGE AT THE HEPARIN BINDING SITE
210, d1br8L_, 0.8621, 2.09, 0.254, 356, 338, IMPLICATIONS FOR FUNCTION AND THERAPY OF A 2.9A STRUCTURE OF BINARY-COMPLEXED ANTITHROMBIN
211, d1e05L_, 0.8616, 2.45, 0.296, 359, 345, PLASMA ALPHA ANTITHROMBIN-III
212, p5c98A_, 0.8614, 2.38, 0.238, 367, 345, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
213, d2b4xL_, 0.8609, 2.38, 0.238, 367, 345, CRYSTAL STRUCTURE OF ANTITHROMBIN-III
214, d1dzgL_, 0.8608, 2.30, 0.312, 366, 343, N135Q-S380C-ANTITHROMBIN-III
215, d3cvmA_, 0.8607, 1.92, 0.257, 343, 334, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
216, d2vdyA_, 0.8607, 2.42, 0.297, 358, 344, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED CORTICOSTEROID BINDING GLOBULIN COMPLEXED WITH CORTISOL
217, d2behL_, 0.8607, 2.36, 0.241, 366, 344, CRYSTAL STRUCTURE OF ANTITHROMBIN VARIANT S137A/V317C/T401C WITH PLASMA LATENT ANTITHROMBIN
218, d8api.1, 0.8604, 2.40, 0.232, 367, 345, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
219, d1lk6L_, 0.8602, 2.31, 0.243, 361, 342, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE
220, d1r1lL_, 0.8601, 2.30, 0.234, 362, 342, STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF)
221, d1e04L_, 0.8600, 2.34, 0.279, 355, 341, PLASMA BETA ANTITHROMBIN-III
222, d1dzhL_, 0.8599, 2.46, 0.299, 358, 344, P14-FLUORESCEIN-N135Q-S380C-ANTITHROMBIN-III
223, d2hijL_, 0.8597, 2.46, 0.302, 358, 344, CRYSTAL STRUCTURE OF P14 ALANINE VARIANT OF ANTITHROMBIN
224, d9api.1, 0.8595, 2.40, 0.300, 357, 343, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
225, p5ei0A_, 0.8587, 2.49, 0.299, 358, 344, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
226, p3zhaQ_, 0.8586, 2.50, 0.302, 358, 344, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
227, d1jvqL_, 0.8586, 2.55, 0.261, 364, 348, CRYSTAL STRUCTURE AT 2.6A OF THE TERNARY COMPLEX BETWEEN ANTITHROMBIN A P14-P8 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE
228, d1d5s.1, 0.8585, 2.44, 0.239, 363, 343, CRYSTAL STRUCTURE OF CLEAVED ANTITRYPSIN POLYMER
229, d1antL_, 0.8584, 2.31, 0.316, 366, 342, BIOLOGICAL IMPLICATIONS OF A 3 ANGSTROMS STRUCTURE OF DIMERIC ANTITHROMBIN
230, d3cvmB_, 0.8582, 1.70, 0.354, 340, 328, HIGH RESOLUTION STRUCTURE OF A STABLE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN ITS PROTEASE CLEAVED FORM
231, d7api.1, 0.8581, 2.84, 0.284, 374, 352, THE S VARIANT OF HUMAN ALPHA1-ANTITRYPSIN STRUCTURE AND IMPLICATIONS FOR FUNCTION AND METABOLISM
232, d4eb1L_, 0.8581, 2.29, 0.244, 360, 340, HYPERSTABLE IN-FRAME INSERTION VARIANT OF ANTITHROMBIN
233, d1oyhL_, 0.8581, 2.59, 0.299, 364, 348, CRYSTAL STRUCTURE OF P13 ALANINE VARIANT OF ANTITHROMBIN
234, p3zhaL_, 0.8577, 2.57, 0.314, 372, 347, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
235, d1sngA1, 0.8574, 2.51, 0.285, 398, 344, STRUCTURE OF A THERMOPHILIC SERPIN IN THE NATIVE STATE
236, p5c98B_, 0.8572, 2.54, 0.285, 398, 344, 1.45A RESOLUTION STRUCTURE OF SRPN18 FROM ANOPHELES GAMBIAE
237, p4au4G_, 0.8565, 2.52, 0.285, 417, 344, CRYSTAL STRUCTURE OF HSP47
238, p3zhaC_, 0.8561, 2.60, 0.209, 359, 345, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
239, p5ei0E_, 0.8560, 2.51, 0.282, 410, 344, STRUCTURE OF RCL-CLEAVED VASPIN (SERPINA12)
240, d1wz9A_, 0.8559, 2.52, 0.282, 409, 344, THE 2.1 A STRUCTURE OF A TUMOUR SUPPRESSING SERPIN
241, p4au4F_, 0.8558, 2.69, 0.299, 377, 348, CRYSTAL STRUCTURE OF HSP47
242, d1ezx.1, 0.8556, 2.40, 0.243, 361, 342, CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
243, p4au4D_, 0.8555, 2.53, 0.285, 403, 344, CRYSTAL STRUCTURE OF HSP47
244, d2arqA_, 0.8553, 2.59, 0.280, 376, 347, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGDGGVMTGR-OH
245, p3zhaA_, 0.8548, 2.56, 0.285, 406, 344, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
246, p4au4C_, 0.8543, 2.55, 0.285, 409, 344, CRYSTAL STRUCTURE OF HSP47
247, d1azxL_, 0.8531, 2.57, 0.288, 412, 344, ANTITHROMBIN/PENTASACCHARIDE COMPLEX
248, d3eoxA_, 0.8523, 2.53, 0.282, 407, 344, HIGH QUALITY STRUCTURE OF CLEAVED PAI-1-STAB
249, d4ro9C_, 0.8519, 2.55, 0.285, 409, 344, 2.0A RESOLUTION STRUCTURE OF SRPN2 (S358E) FROM ANOPHELES GAMBIAE
250, d2arrA_, 0.8518, 2.62, 0.280, 375, 347, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETION MUTANT] COMPLEXED WITH PEPTIDE N-ACETYL-TEAAAGMGGVMTGR-OH
251, d1e03L_, 0.8514, 2.68, 0.236, 372, 348, PLASMA ALPHA ANTITHROMBIN-III AND PENTASACCHARIDE
252, d1qmb.1, 0.8501, 2.68, 0.236, 372, 348, CLEAVED ALPHA-1-ANTITRYPSIN POLYMER
253, d1nq9L_, 0.8499, 2.74, 0.249, 365, 350, CRYSTAL STRUCTURE OF ANTITHROMBIN IN THE PENTASACCHARIDE-BOUND INTERMEDIATE STATE
254, d1jrrA_, 0.8494, 2.60, 0.285, 406, 344, HUMAN PLASMINOGEN ACTIVATOR INHIBITOR-2.[LOOP (66-98) DELETIONMUTANT] COMPLEXED WITH PEPTIDE MIMICKING THE REACTIVE CENTER LOOP
255, p4r9iA_, 0.8488, 2.64, 0.282, 375, 347, CRYSTAL STRUCTURE OF CYSTEINE PROTEINASE INHIBITOR SERPIN18 FROM BOMBYX MORI
256, p4au2D_, 0.8487, 2.48, 0.283, 392, 343, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
257, p3zhaP_, 0.8486, 2.73, 0.299, 377, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
258, p2wy0C_, 0.8485, 2.64, 0.280, 375, 347, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM WITH SPACE GROUP P6122
259, p4au2A_, 0.8478, 2.61, 0.288, 392, 344, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
260, d3evjL_, 0.8475, 2.55, 0.282, 410, 344, INTERMEDIATE STRUCTURE OF ANTITHROMBIN BOUND TO THE NATURAL PENTASACCHARIDE
261, d3dlwA_, 0.8469, 2.82, 0.245, 369, 351, ANTICHYMOTRYPSIN
262, p2wxyC_, 0.8466, 2.20, 0.213, 345, 333, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE REDUCED FORM
263, d1lq8.4, 0.8466, 2.82, 0.207, 364, 348, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
264, p4au4E_, 0.8463, 2.82, 0.207, 364, 348, CRYSTAL STRUCTURE OF HSP47
265, d1lq8.1, 0.8459, 2.68, 0.267, 368, 348, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
266, p4au4B_, 0.8457, 2.79, 0.246, 376, 349, CRYSTAL STRUCTURE OF HSP47
267, d3stoA_, 0.8455, 2.67, 0.236, 371, 347, SERPIN FROM THE TREMATODE SCHISTOSOMA HAEMATOBIUM
268, p4au4A_, 0.8451, 2.47, 0.274, 357, 340, CRYSTAL STRUCTURE OF HSP47
269, p3zhaK_, 0.8449, 2.71, 0.264, 368, 348, MOLECULAR BASIS FOR THE ACTION OF THE COLLAGEN-SPECIFIC CHAPERONE HSP47 SERPINH1 AND ITS STRUCTURE-SPECIFIC CLIENT RECOGNITION.
270, d4c49D_, 0.8441, 2.59, 0.284, 371, 345, REACTIVE LOOP CLEAVED HUMAN CBG IN COMPLEX WITH CORTISOL
271, p4au3D_, 0.8427, 2.69, 0.265, 366, 347, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
272, d1lq8.2, 0.8402, 2.56, 0.322, 360, 342, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
273, p4au2B_, 0.8385, 2.56, 0.322, 360, 342, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
274, d1qmnA_, 0.8372, 2.80, 0.246, 380, 349, ALPHA1-ANTICHYMOTRYPSIN SERPIN IN THE DELTA CONFORMATION (PARTIAL LOOP INSERTION)
275, d4aqhA1, 0.8357, 2.80, 0.246, 380, 349, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
276, p5m3yA_, 0.8355, 2.80, 0.249, 370, 350, CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED ANGIOTENSINOGEN
277, d1lq8.3, 0.8347, 2.67, 0.285, 414, 344, CRYSTAL STRUCTURE OF CLEAVED PROTEIN C INHIBITOR
278, p2wxxC_, 0.8326, 2.71, 0.301, 370, 345, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
279, d4aqhC1, 0.8319, 1.98, 0.276, 336, 326, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
280, d4aqhB1, 0.8317, 2.67, 0.319, 358, 342, PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH THE INHIBITOR AZ3976
281, d1mtp.1, 0.8315, 2.69, 0.285, 423, 344, THE X-RAY CRYSTAL STRUCTURE OF A SERPIN FROM A THERMOPHILIC PROKARYOTE
282, d1athB_, 0.8314, 2.69, 0.285, 423, 344, THE INTACT AND CLEAVED HUMAN ANTITHROMBIN III COMPLEX AS A MODEL FOR SERPIN-PROTEINASE INTERACTIONS
283, p2x0bH_, 0.8309, 2.62, 0.285, 368, 344, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
284, p2x0bF_, 0.8309, 2.73, 0.285, 413, 344, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
285, p2x0bD_, 0.8309, 2.64, 0.320, 357, 341, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
286, p2x0bB_, 0.8309, 2.61, 0.157, 378, 343, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN COMPLEXED WITH RENIN
287, p4au3B_, 0.8298, 2.61, 0.157, 378, 343, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
288, p2wxwA_, 0.8294, 2.59, 0.263, 359, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSINOGEN
289, d3lw2A_, 0.8290, 2.88, 0.249, 373, 349, MOUSE PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
290, d2pefA_, 0.8281, 2.79, 0.164, 424, 347, CRYSTAL STRUCTURE OF A THERMOPHILIC SERPIN TENGPIN IN THE LATENT STATE
291, p2wxzA_, 0.8279, 2.82, 0.250, 367, 348, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
292, p2wxxD_, 0.8272, 2.80, 0.288, 417, 344, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
293, p5cdzA_, 0.8270, 2.75, 0.304, 360, 339, CRYSTAL STRUCTURE OF CONSERPIN IN THE LATENT STATE
294, p4au3C_, 0.8261, 2.84, 0.156, 419, 347, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
295, p4au3A_, 0.8261, 2.51, 0.254, 359, 338, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
296, p2wxxA_, 0.8248, 2.80, 0.251, 367, 347, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
297, p2wxxB_, 0.8240, 2.50, 0.254, 358, 338, CRYSTAL STRUCTURE OF MOUSE ANGIOTENSINOGEN IN THE OXIDISED FORM
298, p2wxzC_, 0.8213, 2.88, 0.249, 368, 349, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN C2 SPACE GROUP
299, d4kdsA_, 0.8205, 2.57, 0.252, 361, 337, CRYSTAL STRUCTURE OF LATENT RAINBOW TROUT PLASMINOGEN ACTIVATOR INHIBITOR 1 (PAI-1)
300, p2wy1B_, 0.8205, 2.57, 0.252, 361, 337, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
301, p2wy1A_, 0.8205, 2.76, 0.266, 366, 346, CRYSTAL STRUCTURE OF RAT ANGIOTENSINOGEN IN P321 SPACE GROUP
302, d1c5gA_, 0.8183, 2.93, 0.249, 374, 349, PLASMINOGEN ACTIVATOR INHIBITOR-1
303, d1iz2A_, 0.8126, 2.43, 0.238, 356, 336, INTERACTIONS CAUSING THE KINETIC TRAP IN SERPIN PROTEIN FOLDING
304, d1dvnA_, 0.8120, 2.76, 0.257, 359, 343, LATENT FORM OF PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1)
305, d1lj5A_, 0.8090, 2.52, 0.255, 357, 337, 1.8A RESOLUTION STRUCTURE OF LATENT PLASMINOGEN ACTIVATOR INHIBITOR-1(PAI-1)
306, d2oayA1, 0.8083, 2.59, 0.263, 354, 338, CRYSTAL STRUCTURE OF LATENT HUMAN C1-INHIBITOR
307, d2v95A_, 0.8067, 3.03, 0.314, 365, 341, STRUCTURE OF CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH CORTISOL
308, d2v6dA_, 0.8066, 2.94, 0.306, 379, 343,  
309, d2vh4A_, 0.8057, 2.75, 0.152, 418, 342, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
310, p4ajuA_, 0.8043, 2.62, 0.255, 357, 337, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN P41 SPACE GROUP
311, p4yiaA_, 0.8042, 2.88, 0.162, 422, 345, STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN
312, p5m3xB_, 0.8035, 3.00, 0.306, 379, 343, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
313, p4au2C_, 0.8032, 2.99, 0.306, 379, 343, CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX
314, p2riwA_, 0.8030, 2.65, 0.215, 355, 335, THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN COMPLEXED WITH THYROXINE
315, p2xn5A_, 0.8027, 2.65, 0.215, 355, 335, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH FUROSEMIDE
316, p2xn6A_, 0.8026, 2.60, 0.288, 362, 333, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN
317, p2rivA_, 0.8022, 2.83, 0.140, 409, 342, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED HUMAN THYROXINE BINDING GLOBULIN
318, p2xn7A_, 0.8020, 2.83, 0.140, 409, 342, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH THYROXINE-FLUORESEIN (T405-CF)
319, p2xn3A_, 0.8019, 2.84, 0.137, 408, 342, CRYSTAL STRUCTURE OF THYROXINE-BINDING GLOBULIN COMPLEXED WITH MEFENAMIC ACID
320, p5m3xA_, 0.8012, 2.83, 0.140, 409, 342, CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN I-DELETED ANGIOTENSINOGEN
321, d2vh4B_, 0.7985, 2.77, 0.233, 351, 339, STRUCTURE OF A LOOP C-SHEET SERPIN POLYMER
322, d1c8o.1, 0.7950, 2.85, 0.146, 438, 342, 2.9 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
323, p5ncwA_, 0.7890, 2.85, 0.146, 438, 342, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN (V367K/K368A MUTANT).
324, p3nddA_, 0.7842, 2.62, 0.285, 365, 333, CLEAVED ANTITRYPSIN WITH P10 PRO AND P9-P6 ASP
325, p3ndfA_, 0.7819, 2.93, 0.279, 366, 337, CLEAVED ANTITRYPSIN WITH P8-P6 ASP
326, d2d26A1, 0.7795, 3.08, 0.153, 422, 346, ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
327, d9paiA_, 0.7784, 2.96, 0.151, 411, 344, CLEAVED SUBSTRATE VARIANT OF PLASMINOGEN ACTIVATOR INHIBITOR-1
328, p5ncuA_, 0.7757, 2.87, 0.384, 361, 336, STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
329, p3t1pA_, 0.7755, 3.02, 0.259, 357, 343, CRYSTAL STRUCTURE OF AN ALPHA-1-ANTITRYPSIN TRIMER
330, p5nctA_, 0.7693, 2.91, 0.249, 354, 341, STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR MIROPIN.
331, d1f0c.1, 0.7674, 2.98, 0.166, 412, 344, STRUCTURE OF THE VIRAL SERPIN CRMA
332, p3dy0A_, 0.7673, 3.05, 0.162, 428, 345, CRYSTAL STRUCTURE OF CLEAVED PCI BOUND TO HEPARIN
333, d1m93.1, 0.7582, 2.94, 0.155, 413, 341, 1.65 A STRUCTURE OF CLEAVED VIRAL SERPIN CRMA
334, d2znhA_, 0.7580, 2.84, 0.290, 370, 335, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
335, d2znhB_, 0.7564, 3.01, 0.155, 417, 343, CRYSTAL STRUCTURE OF A DOMAIN-SWAPPED SERPIN DIMER
336, d1jjo.2, 0.7456, 3.01, 0.155, 418, 343, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
337, d1jjo.1, 0.7456, 3.25, 0.303, 379, 343, CRYSTAL STRUCTURE OF MOUSE NEUROSERPIN (CLEAVED FORM)
338, p4pywA1, 0.6810, 3.25, 0.303, 379, 343, 1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX
339, p4bb2A1, 0.6325, 3.00, 0.294, 371, 337, CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE
340, p4afxA1, 0.5990, 3.30, 0.304, 379, 342, CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP
341, p5om7A1, 0.5930, 3.26, 0.304, 379, 339, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN 
342, p5om2A1, 0.5924, 2.88, 0.264, 366, 330, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE 
343, p5om5A1, 0.5892, 2.69, 0.193, 342, 327, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE 
344, p5om8A1, 0.5879, 2.69, 0.193, 342, 327, CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
345, p5om6A1, 0.5875, 3.17, 0.278, 380, 335, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
346, p2h4qA1, 0.5868, 2.53, 0.244, 338, 320, CRYSTAL STRUCTURE OF A M-LOOP DELETION VARIANT OF MENT IN THE CLEAVED CONFORMATION
347, p5om3A1, 0.5863, 2.55, 0.254, 337, 319, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
348, p2h4pA1, 0.5862, 2.96, 0.147, 387, 334, CRYSTAL STRUCTURE OF WILDTYPE MENT IN THE CLEAVED CONFORMATION
349, p6ftpA1, 0.5714, 2.51, 0.262, 338, 321, CRYSTAL FORM 1 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN 
350, p5om6C1, 0.5681, 2.55, 0.254, 337, 319, CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE 
351, p3f02B1, 0.5612, 2.59, 0.253, 341, 320, CLEAVED HUMAN NEUROSERPIN
352, p3f02A1, 0.5481, 2.55, 0.254, 337, 319, CLEAVED HUMAN NEUROSERPIN
